Hims & Hers (HIMS) stock is sinking 20% today after ... Eli Lilly disclosed today that it had started selling 7.5 milligram and 10 milligram vials of Zepbound, its popular weight-loss drug ...

Hims & Hers (HIMS) made a killing last year selling ... which lets Ro offer its members cheaper Zepbound in vials rather than the standard auto-injector pens. However, he added, that there is ...

Citi analyst Daniel Grosslight keeps a Sell rating on Hims & Hers (HIMS) with a $27 price target ... LillyDirect offering that provides access to Tirzepatide vials to cash pay customers for ...

Hims & Hers is stopping its sales of an alternative ... the drug company is cutting the price of its 7.5 mg and 10 mg single-dose vials. "Lilly is committed to working with all parties to ...

The move: Hims & Hers stock plunged by as much as 27% on Tuesday ... announced on Tuesday that it would lower the price of its drugs in vial form for people paying out of pocket rather than ...

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY ... Eli Lilly disclosed today that it had started selling 7.5 milligram and 10 milligram vials of Zepbound, its popular weight-loss ...

Hims & Hers stock fell by 27% as it announced plans ... announced on Tuesday that it would lower the price of its drugs in vial form for people paying out of pocket rather than using insurance.

announced on Tuesday that it would lower the price of its drugs in vial form for people paying out of pocket rather than using insurance. What the pros are saying: Citi estimated that GLP-1 drugs ...

Eli Lilly began offering vials of the two lowest doses of Zepbound ... for their versions of Zepbound and Wegovy in the U.S. Hims & Hers forecast sales of $725 million from its weight-loss ...

February 25, 2025 Hims & Hers shares plunge as looming curbs on ... Healthcare & Pharmaceuticalscategory· August 27, 2024 Lilly launches vials of weight-loss drug Zepbound for as low as $399 ...